[Journal logo]

Volume 67 
Part 1 
Page o229  
January 2011  

Received 18 October 2010
Accepted 19 December 2010
Online 24 December 2010

Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.005 Å
R = 0.045
wR = 0.110
Data-to-parameter ratio = 7.3
Details
Open access

4-[(7-Fluoroquinazolin-4-yl)oxy]aniline

aSchool of Pharmaceutical Sciences, Nanjing University of Technology, No. 5 Xinmofan Road, Nanjing 210009, People's Republic of China,bJiangsu Provincial Institute of Materia Medica, Nanjing University of Technology, No. 26 Majia Street, Nanjing 210009, People's Republic of China, and cPRC DAYAOWAN Administration for Entry & Exit Inspection and Quarantine, Haiqingdao Foreign Area Development Zone, Dalian 116610, Liaoning Province, People's Republic of China
Correspondence e-mail: jiajing.jj@gmail.com

In the molecule of the title compound, C14H10FN3O, the bicyclic quinazoline system is effectively planar, with a mean deviation from planarity of 0.0140 (3) Å. The quinazoline heterocyclic system and the adjacent benzene ring make a dihedral angle of 85.73 (9)°. Two intermolecular N-H...N hydrogen bonds contribute to the stability of the crystal structure. In addition, a weak [pi]-[pi] stacking interaction [centroid-centroid distance = 3.902 (2) Å] is observed.

Related literature

For general background to quinazolines, see: Labuda et al. (2009[Labuda, J., Ovadekova, R. & Galandova, J. (2009). Mikrochim. Acta, 164, 371-377.]). Graves et al. (2002[Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M. & Haystead, T. A. J. (2002). Mol. Pharmacol. 62, 1364-1372.]); For the preparation of the title compound, see: Zhang et al. (2010[Zhang, A. H., Yuan, S. T., Shen, Y. P., Wu, Y. D. & Ji, A. C. (2010). CN Patent Appl. CN101671301.]). For bond-length data, see: Allen et al. (1987[Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.]).

[Scheme 1]

Experimental

Crystal data
  • C14H10FN3O

  • Mr = 255.25

  • Orthorhombic, P 21 21 21

  • a = 8.0210 (16) Å

  • b = 8.3370 (17) Å

  • c = 17.562 (4) Å

  • V = 1174.4 (4) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.11 mm-1

  • T = 293 K

  • 0.30 × 0.20 × 0.10 mm

Data collection
  • Enraf-Nonius CAD-4 diffractometer

  • Absorption correction: [psi] scan (North et al., 1968[North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351-359.]) Tmin = 0.969, Tmax = 0.990

  • 2351 measured reflections

  • 1256 independent reflections

  • 883 reflections with I > 2[sigma](I)

  • Rint = 0.082

  • 3 standard reflections every 200 reflections intensity decay: 1%

Refinement
  • R[F2 > 2[sigma](F2)] = 0.045

  • wR(F2) = 0.110

  • S = 1.02

  • 1256 reflections

  • 172 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.12 e Å-3

  • [Delta][rho]min = -0.15 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N1-H1A...N2i 0.89 2.67 3.408 (4) 142
N1-H1B...N3ii 0.89 2.38 3.205 (4) 154
Symmetry codes: (i) [x+{\script{1\over 2}}, -y-{\script{1\over 2}}, -z+1]; (ii) [-x+{\script{1\over 2}}, -y, z-{\script{1\over 2}}].

Data collection: CAD-4 EXPRESS (Enraf-Nonius, 1994[Enraf-Nonius (1994). CAD-4 EXPRESS. Enraf-Nonius, Delft, The Netherlands.]); cell refinement: CAD-4 EXPRESS; data reduction: XCAD4 (Harms & Wocadlo, 1995[Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany.]); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXL97 and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: ZL2317 ).


Acknowledgements

The authors thank the Center of Testing and Analysis, Nanjing University, for the data collection.

References

Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Enraf-Nonius (1994). CAD-4 EXPRESS. Enraf-Nonius, Delft, The Netherlands.
Graves, P. R., Kwiek, J. J., Fadden, P., Ray, R., Hardeman, K., Coley, A. M., Foley, M. & Haystead, T. A. J. (2002). Mol. Pharmacol. 62, 1364-1372.  [CrossRef] [PubMed] [ChemPort]
Harms, K. & Wocadlo, S. (1995). XCAD4. University of Marburg, Germany.
Labuda, J., Ovadekova, R. & Galandova, J. (2009). Mikrochim. Acta, 164, 371-377.  [CrossRef] [ChemPort]
North, A. C. T., Phillips, D. C. & Mathews, F. S. (1968). Acta Cryst. A24, 351-359.  [CrossRef] [details]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Zhang, A. H., Yuan, S. T., Shen, Y. P., Wu, Y. D. & Ji, A. C. (2010). CN Patent Appl. CN101671301.


Acta Cryst (2011). E67, o229  [ doi:10.1107/S1600536810053286 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.